A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTD

Clinical trial NCT04993755 · COMPLETED

Trial details

NCT number: NCT04993755
Sponsor: Transposon Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis Frontotemporal Dementia

Start date: 2021-10-01
Primary completion: 2023-08-17
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.